WOC

The WOC Skin Health Weekly®, a weekly e-news publication packed with career empowerment resources including the latest clinical, industry, and product news, clinical education, market research, and of course, the most recently posted jobs requiring expertise in the prevention and treatment of skin breakdown and wound care. Over 20,000 clinicians now receive the WOC Skin Health Weekly.

Read the most recent issue of the WOC Skin Health Weekly®

Receive your own complimentary subscription to the WOC Skin Health Weekly®

Sign Up Now!


Featured Articles

December 12, 2018

Shape-Shifting Cell Breakthrough 

A new computational model developed by researchers from The City College of New York and Yale gives a clearer picture of the structure and mechanics of soft, shape-changing cells that could provide a better understanding of cancerous tumor growth, wound healing, and embryonic development. Read More

New Insole Uses Oxygen to Help Heal Diabetes-Related Foot Ulcers

When it comes to treating, managing, and preventing diabetes-related complications, it seems oxygen is a key ingredient. Along that line, researchers at Purdue University have created a customizable insole to treat diabetic foot ulcers. It’s similar to evolving medical technology with contact lenses that help prevent and treat diabetic retinopathy. Read More

New ATTRACT Data Show Catheter-Based Therapy Significantly Reduces Leg Symptoms and PTS Severity to Two Years

A new study, recently published online in the journal Circulation, reports on outcomes from a subgroup of 391 patients with acute iliofemoral deep venous thrombosis (DVT) in whom pharmacomechanical catheter-directed thrombolysis (PCDT) was evaluated within the ATTRACT trial.  Read More

Carriage of ESBL-PE May Increase the Risk of Colorectal Surgical Site Infections

Although the 2013 Infectious Diseases Society of America and 2017 US Centers for Disease Control and Prevention (CDC) guidelines recommend a combination of oral antimicrobials, mechanical bowel preparation (MBP), and intravenous (IV) cephalosporin and metronidazole for colorectal surgical prophylaxis, screening for extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-PE) in high-risk patients and coverage are not included. Despite the high rates of morbidity and mortality with ESBL-PE infections, little is known about the prevalence of ESBL-PE fecal carriage and its effect on rates of surgical site infections (SSIs) after colorectal surgery. Read More